Interactions of VIP, secretin and PACP1-38 with phospholipids: A biological paradox revisited

Current Pharmaceutical Design

Volumn 9, Issue 12, 2003, Pages 1005-1012

  Krishnadas, A ^a   Onyuksel H ^a,b   Rubinstein, I ^a,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b University of Illinois at Chicago   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

helix; Amphipathic neuropeptides; Bioavailability; Conformation; in vivo stability; Phospholipids

Indexed keywords

CALMODULIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; LIPOSOME; LONG ACTING DRUG; NEUROPEPTIDE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPID; RECEPTOR SUBTYPE; SECRETIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALPHA HELIX; AQUEOUS SOLUTION; BIOMIMETICS; BODY FLUID; CONCENTRATION (PARAMETERS); CONFORMATIONAL TRANSITION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; HUMAN; IN VIVO STUDY; LIPID MONOLAYER; MOLECULAR RECOGNITION; NONHUMAN; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STABILITY; PROTEIN TARGETING; REVIEW;

ANIMALS; HUMANS; NEUROPEPTIDES; PEPTIDE FRAGMENTS; PHOSPHOLIPIDS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; SECRETIN; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0037269112     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612033455206     Document Type: Review

References (62)

1. Said SI. J Endocrinol Invest 1986; 9: 191.
2. Widdicombe JG. Am J Respir Crit Care Med 1998; 158: S171.
3. Gomariz R P, Martinez C, Abad C, Leceta J, Delgado M. Curr Pharm Des 2001; 7: 89.
4. Bayliss W M, Starling EH. J Physiol 1902; 28: 325.
5. Mutt V, Jorpes J E, Magnusson S. Eur J Biochem 1970; 15: 513.
6. Chey W Y C, TM, Lee KY, Rominger J, Rhodes RA, You CH. In Gut Hormones; Bloom SR, Polak JM. Ed; Churchill Livingston: Edinburgh 1981.
7. Chang C H, Chey W Y, Erway B, Coy D H, Chang T M. Am J Physiol 1998; 275: G192.
8. Vaudry D, Gonzalez B J, Basille M, Yon L, Fournier A, Vaudry H. Pharmacol Rev 2000; 52: 269.
9. Gololobov G, Noda Y, Sherman S, Rubinstein I, Baranowska-Kortylewicz J, Paul S. J Pharmacol Exp Ther 1998; 285: 753.
10. Paul S, Ebadi M. Neurochem Int 1993; 23: 197.
11. Suzuki H, Gao X P, Olopade C O, Rubinstein I. Am J Physiol 1996; 271: R393.
12. Huang M, Rorstad O P. Peptides 1987; 8: 477.
13. Said S I. Ann N Y Acad Sci 1996; 805: 379.
14. Said S I. J Clin Invest 1996; 97: 2163.
15. Gardner J D, Jensen R T. Recent Prog Horm Res 1983; 39: 211.
16. Dockray G J. In Gut Peptides: Biochemistry and Physiology; Walsh J, Dockray GJ. Ed; Raven Press Ltd: New York 1994.
17. Ulrich C D, 2nd Holtmann M, Miller L J. Gastroenterology 1998; 114: 382.
18. Gao X P, Noda Y, Rubinstein I, Paul S. Life Sci 1994; 54: L247.
19. Inooka H, Endo S, Kitada C, Mizuta E, Fujino M. Int J Pept Protein Res 1992; 40: 456.
20. New R R C. Liposomes; Oxford University Press: New York 1997.
21. Kwon G S O T. Advanced Drug Delivery Reviews 1996; 21: 107.
22. Trubetskoy V S T V P. Advanced Drug Delivery Reviews 1995; 16: 311.
23. Yokoyama M, Sugiyama T, Okano T, Sakurai Y, Naito M, Kataoka K. Pharm Res 1993; 10: 895.
24. Onyuksel H, Ikezaki H, Patel M, Gao X P, Rubinstein I. Pharm Res 1999; 16: 155.
25. Onyuksel H, Ashok B, Rubinstein I 61st International Congress of FIP Singapore 2001; p 82.
26. Weissig V, Whiteman K R, Torchilin V P. Pharm Res 1998; 15: 1552.
27. Schutt C. In Newsletter Nat Alliance for Autism Res, 1998; Vol 4.
28. Caughey G H, Leidig F, Viro N F, Nadel J A. J Pharmacol Exp Ther 1988; 244: 133.
29. Hachisu M, Hiranuma T, Tani S, Iizuka T. J Pharmacobiodyn 1991; 14: 126.
30. Paul S, Mei S, Mody B, Eklund S H, Beach C M, Massey R J, et al. J Biol Chem 1991; 266: 16128.
31. Mody R, Tramontano A, Paul S. Int J Pept Protein Res 1994; 44: 441.
32. Onyuksel H, Bodalia B, Sethi V, Dagar S, Rubinsteina I. Peptides 2000; 21: 419.
33. Rubinstein I, Patel M, Ikezaki H, Dagar S, Onyuksel H. Peptides 1999; 20: 1497.
34. Gandhi S, Rubinstein I, Tsueshita T, Onyuksel H. Peptides 2002; 23: 201.
35. Gandhi S, Tsueshita T, Onyuksel H, Chandiwala R, Rubinstein I. Peptides 2002; 23: 1433.
36. Tsueshita T, Gandhi S, Onyuksel H, Rubinstein I. J Applied Physiology 2002; 93: 1377.
37. Gandhi S, Onyuksel H, Tsueshita T, Rubinstein I Int Symp Controlled Release San Diego 2001; p 572.
38. Carpenter K A, Schiller P W. Biochemistry 1998; 37: 16967.
39. Xia W J, Onyuksel H. Pharm Res 2000; 17: 612.
40. Mozsolits H, Lee T H, Wirth H J, Perlmutter P, Aguilar M I. Biophys J 1999; 77: 1428.
41. Bennes R, Calas B, Chabrier P E, Demaille J, Heitz F. FEBS Lett 1990; 276: 21.
42. Noda Y, Rodriguez-Sierra J, Liu J, Landers D, Mori A, Paul S. Biochim Biophys Acta 1994; 1191 324.
43. Bodanszky M, Bodanszky A. Peptides 1986; 7: 43.
44. Robinson R M, Blakeney E W, Jr, Mattice W L. Biopolymers 1982; 21: 1271.
45. Hamed M M, Robinson R M, Mattice W L. Biopolymers 1983; 22: 1003.
46. Dagar S, Bhakta Y, Onyuksel H, Rubinstein I AAPS Annual Meeting Pharm Sci Supplement Indianapolis IN 2000; p Abstract #2297.
47. Bodanszky M B A, Klausner Y S, Said S I. Bioorganic Chemistry 1974; 3: 133.
48. Refai E, Jonsson C, Andersson M, Jacobsson H, Larsson S, Kogner P, Hassan M. Nucl Med Biol 1999; 26: 931.
49. Ichikawa S, Sreedharan S P, Owen R L, Goetzl E J. Am J Physiol 1995; 268: L584.
50. Brizzolara A L, Burnstock G. Br J Pharmacol 1991; 103: 1206.
51. Gardiner S M, Rakhit T, Kemp P A, March J E, Bennett T. Br J Pharmacol 1994; 111: 589.
52. Rubinstein I, Mayhan W G. J Lab Clin Med 1995; 125: 313.
53. Suzuki H, Noda Y, Paul S, Gao X P, Rubinstein I. Life Sci 1995; 57: 1451.
54. Sejourne F, Suzuki H, Alkan-Onyuksel H, Gao X P, Ikezaki H, Rubinstein I. Am J Physiol 1997; 273: R287.
55. Omary M B, Kagnoff M F. Science 1987; 238 1578.
56. Ikezaki H, Patel M, Onyuksel H, Akhter S R, Gao X-P, Rubinstein I. Am J Physiol 1999; 276: R1359.
57. Keire D A, Mannon P, Kobayashi M, Walsh J H, Solomon T E, Reeve JR Jr. Am J Physiol Gastrointest Liver Physiol 2000; 279: G126.
58. Keire DA, Kobayashi M, Solomon T E, Reeve J R Jr. Biochemistry 2000; 39: 9935.
59. Bettio A, Dinger M C, Beck-Sickinger A G. Protein Sci 2002; 11: 1834.
60. Gomariz RP, Martinez C, Abad C, Leceta J, Delgado M. Curr Pharm Des 2001; 7(2): 89-111.
61. Hoare SR, Usdin TB. Curr Pharm Des 2001; 7(8): 689-713.
62. Jose Cazzulo J, Stoka V, Turk V. Curr Pharm Des 2001; 7(12): 1143-56.